Aerami Therapeutics

Durham, United States

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.

$5.4M raised

Sep 2022

Series B

Biotechnology Diabetes Health Care Medical Therapeutics

Top Investors

SternAegis Molex Ventures John Patton

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aerami Therapeutics

How much funding has Aerami Therapeutics raised?

Aerami Therapeutics has raised $5.4M in total funding. The most recent round was Series B. The last funding was announced in September 2022.

Who are Aerami Therapeutics's investors?

Aerami Therapeutics's investors include SternAegis, Molex Ventures, John Patton.

Where is Aerami Therapeutics headquartered?

Aerami Therapeutics is headquartered in Durham, United States.

What does Aerami Therapeutics do?

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.

What stage is Aerami Therapeutics at?

Aerami Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 20, 2022.

MLA

"Aerami Therapeutics — Funding & Investors." VCBacked, September 20, 2022, https://www.vcbacked.co/company/aerami-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Aerami Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/aerami-therapeutics

Wikipedia (cite web)

{{cite web |title=Aerami Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aerami-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 20, 2022.